Literature DB >> 30981032

Patient-reported health problems and healthcare use after treatment for early-stage breast cancer.

K M de Ligt1, M Heins2, J Verloop3, C H Smorenburg4, J C Korevaar2, S Siesling5.   

Abstract

BACKGROUND: A clear picture of treatment-related health problems following breast cancer treatment is useful in anticipating the informational and other needs of patients during follow-up. This study aimed to identify treatment-related health problems in breast cancer patients up to five years after diagnosis. Secondly, the use of care associated with these health problems was identified.
METHODS: 876 surgically-treated female patients diagnosed between 2012 and 2016 with early-stage breast cancer were asked to complete an online survey about their current health problems and use of care. Multivariate logistic regression analyses were applied to determine the effect of patient and treatment characteristics on health problems.
RESULTS: 404 patients responded (46%). The median age was 62.0 years (SD:10.9). Apart from breast surgery, patients had been treated with radiotherapy (72%), chemotherapy (49%), anti-hormonal therapy (57%), and axillary dissection (21%). Ninety-three percent experienced one or more health problems. Over 50% of respondents experienced fatigue, psychological problems, and health problems regarding the breast, and/or musculoskeletal, central nervous, and reproductive system. Treatment with chemotherapy was significantly associated (p < 0.05) with an increased risk of health problems, respectively fatigue (OR:2.00), respiratory (OR:1.81), gastrointestinal (OR:1.87), central nervous (OR:3.40), and skin problems (OR:2.62). Use of healthcare for one or more health problems was reported by 64% of respondents. DISCUSSION: Almost all patients experienced health problems up to five years after breast cancer diagnosis, with a range of complaints that were consistently present over time. Factors associated with the development of health problems are useful for better informing patients beforehand and targeting follow-up care.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast neoplasms; Follow-up care; Late effects; Personalised care; Survivorship

Year:  2019        PMID: 30981032     DOI: 10.1016/j.breast.2019.03.010

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  6 in total

1.  Varying severities of symptoms underline the relevance of personalized follow-up care in breast cancer survivors: latent class cluster analyses in a cross-sectional cohort.

Authors:  Kelly M de Ligt; Belle H de Rooij; Iris Walraven; Marianne J Heins; Janneke Verloop; Sabine Siesling; Joke C Korevaar; Lonneke V van de Poll-Franse
Journal:  Support Care Cancer       Date:  2022-06-21       Impact factor: 3.359

2.  Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study).

Authors:  A M May; E M Monninkhof; E W Koevoets; S B Schagen; M B de Ruiter; M I Geerlings; L Witlox; E van der Wall; M M Stuiver; G S Sonke; M J Velthuis; J J Jobsen; M B E Menke-Pluijmers; E Göker; C C van der Pol; M E M M Bos; L W Tick; N A van Holsteijn; J van der Palen
Journal:  Breast Cancer Res       Date:  2022-05-26       Impact factor: 8.408

3.  The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors.

Authors:  K M de Ligt; M Heins; J Verloop; N P M Ezendam; C H Smorenburg; J C Korevaar; S Siesling
Journal:  Breast Cancer Res Treat       Date:  2019-09-11       Impact factor: 4.872

4.  Impact of Psycho-Social Factors on Fatigue among Breast Cancer Patients Who Are Currently Undergoing Radiotherapy.

Authors:  Hyesun Park; Kisook Kim
Journal:  Int J Environ Res Public Health       Date:  2020-08-21       Impact factor: 3.390

5.  Cocreation with Dutch patients of decision-relevant information to support shared decision-making about adjuvant treatment in breast cancer care.

Authors:  Inge S van Strien-Knippenberg; Marieke C S Boshuizen; Domino Determann; Jasmijn H de Boer; Olga C Damman
Journal:  Health Expect       Date:  2022-05-17       Impact factor: 3.318

6.  Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial.

Authors:  Jolyn Hersch; Alexandra Barratt; Kevin McGeechan; Jesse Jansen; Nehmat Houssami; Haryana Dhillon; Gemma Jacklyn; Les Irwig; Kirsten McCaffery
Journal:  J Natl Cancer Inst       Date:  2021-11-02       Impact factor: 13.506

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.